DNA adducts and related biomarkers in populations exposed to environmental carcinogens.
Prevention of environmentally related cancer will be enhanced by the availability of sensitive early warning systems and by improvements in quantitative assessment of human risks. Accordingly, we have carried out a series of molecular epidemiologic studies aimed at validating a panel of biologic markers, including carcinogen-DNA and -protein adducts, sister chromatid exchange, micronucleus formation, DNA strand breaks, and DNA repair capacity. Results from three such studies illustrate the usefulness of these biomarkers in elucidating low-dose-response relationships, correlations between biomarkers, and the range of variation in biomarkers between individuals exposed to similar concentrations of carcinogens. Low-level workplace or ambient exposures to styrene, ethylene oxide, and polycyclic aromatic hydrocarbons (PAH) were associated with significant increases in both molecular dose of carcinogens (adducts) and various markers of preclinical effects. Correlations between biomarkers varied by exposure. For example, in the styrene study, sister chromatid exchange frequency was not correlated with any of the markers, in contrast to the studies of ethylene oxide and PAH. Significant molecular effects were observed not only in occupationally exposed people but also in residents of an area in Poland characterized by high levels of air pollution. For example, the mean PAH-DNA level in exposed residents (winter sample) was 30.4 adducts per 10(8) nucleotides. This level was significantly higher than that of adducts seen in summer samples from the same area (4.2/10(8), or in winter samples from residents of a rural area (11.01/10(8). Significant seasonal variation in PAH-DNA adduct formation in this group was consistent with recorded fluctuations in air pollution levels. Striking interindividual variation was observed in all three exposed populations.
Perera
F
F
Columbia University School of Public Health, New York, NY 10032.
Brenner
D
D
Jeffrey
A
A
Mayer
J
J
Tang
D
D
Warburton
D
D
Young
T I
TI
Wazneh
L
L
Latriano
L
L
Motykiewicz
G
G
D015415:Biomarkers / Q000097:blood; D004260:DNA Repair / Q000187:drug effects; D005027:Ethylene Oxide / Q000009:adverse effects / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D048629:Micronuclei, Chromosome-Defective / Q000187:drug effects; D016273:Occupational Exposure / Q000009:adverse effects / Q000032:analysis*; D011083:Polycyclic Compounds / Q000009:adverse effects / Q000097:blood*; D012854:Sister Chromatid Exchange / Q000187:drug effects; D020058:Styrene; D013343:Styrenes / Q000009:adverse effects / Q000097:blood*
D015415:Biomarkers; D011083:Polycyclic Compounds; D013343:Styrenes; D020058:Styrene; D005027:Ethylene Oxide